Bluejay Diagnostics (BJDX) Revenue & Revenue Breakdown
Bluejay Diagnostics Revenue Highlights
00
Bluejay Diagnostics Revenue by Period
Bluejay Diagnostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $249.04K | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Bluejay Diagnostics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Bluejay Diagnostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $216.09K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $1.45M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $249.04K | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Bluejay Diagnostics generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Bluejay Diagnostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VERO | Venus Concept | $64.83M | $13.64M |
| NAOV | NanoVibronix | $2.28M | $494.00K |
| MOVE | Movano | $1.01M | $103.00K |
| ACON | Aclarion | $45.72K | $18.99K |
| BBLG | Bone Biologics | - | - |
| CNSP | CNS Pharmaceuticals | - | - |
| BJDX | Bluejay Diagnostics | - | - |
| AMIX | Autonomix Medical | - | - |
| NDRA | ENDRA Life Sciences | - | - |
| CMND | Clearmind Medicine | - | - |
| WINT | Windtree Therapeutics | - | - |